92 related articles for article (PubMed ID: 17118337)
1. Peptide modulators of Src activity in G1 regulate entry into S phase and proliferation of NIH 3T3 cells.
Mamidipudi V; Miller LD; Mochly-Rosen D; Cartwright CA
Biochem Biophys Res Commun; 2007 Jan; 352(2):423-30. PubMed ID: 17118337
[TBL] [Abstract][Full Text] [Related]
2. RACK1 regulates G1/S progression by suppressing Src kinase activity.
Mamidipudi V; Zhang J; Lee KC; Cartwright CA
Mol Cell Biol; 2004 Aug; 24(15):6788-98. PubMed ID: 15254245
[TBL] [Abstract][Full Text] [Related]
3. RACK1 inhibits colonic cell growth by regulating Src activity at cell cycle checkpoints.
Mamidipudi V; Dhillon NK; Parman T; Miller LD; Lee KC; Cartwright CA
Oncogene; 2007 May; 26(20):2914-24. PubMed ID: 17072338
[TBL] [Abstract][Full Text] [Related]
4. RACK1 regulates Src-mediated Sam68 and p190RhoGAP signaling.
Miller LD; Lee KC; Mochly-Rosen D; Cartwright CA
Oncogene; 2004 Jul; 23(33):5682-6. PubMed ID: 15184885
[TBL] [Abstract][Full Text] [Related]
5. SHP-2 is a novel target of Abl kinases during cell proliferation.
Mitra S; Beach C; Feng GS; Plattner R
J Cell Sci; 2008 Oct; 121(Pt 20):3335-46. PubMed ID: 18827006
[TBL] [Abstract][Full Text] [Related]
6. RACK1, a receptor for activated C kinase and a homolog of the beta subunit of G proteins, inhibits activity of src tyrosine kinases and growth of NIH 3T3 cells.
Chang BY; Conroy KB; Machleder EM; Cartwright CA
Mol Cell Biol; 1998 Jun; 18(6):3245-56. PubMed ID: 9584165
[TBL] [Abstract][Full Text] [Related]
7. Distinct p53-mediated G1/S checkpoint responses in two NIH3T3 subclone cells following treatment with DNA-damaging agents.
Huang TS; Kuo ML; Shew JY; Chou YW; Yang WK
Oncogene; 1996 Aug; 13(3):625-32. PubMed ID: 8760304
[TBL] [Abstract][Full Text] [Related]
8. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
[TBL] [Abstract][Full Text] [Related]
9. RACK1 inhibits the serum- and anchorage-independent growth of v-Src transformed cells.
Mamidipudi V; Chang BY; Harte RA; Lee KC; Cartwright CA
FEBS Lett; 2004 Jun; 567(2-3):321-6. PubMed ID: 15178345
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth.
Migliaccio A; Varricchio L; De Falco A; Castoria G; Arra C; Yamaguchi H; Ciociola A; Lombardi M; Di Stasio R; Barbieri A; Baldi A; Barone MV; Appella E; Auricchio F
Oncogene; 2007 Oct; 26(46):6619-29. PubMed ID: 17486077
[TBL] [Abstract][Full Text] [Related]
11. Role of atypical protein kinase C in estradiol-triggered G1/S progression of MCF-7 cells.
Castoria G; Migliaccio A; Di Domenico M; Lombardi M; de Falco A; Varricchio L; Bilancio A; Barone MV; Auricchio F
Mol Cell Biol; 2004 Sep; 24(17):7643-53. PubMed ID: 15314172
[TBL] [Abstract][Full Text] [Related]
12. Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation.
Yun MS; Kim SE; Jeon SH; Lee JS; Choi KY
J Cell Sci; 2005 Jan; 118(Pt 2):313-22. PubMed ID: 15615777
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cell cycle entry and G1 progression by CSF-1.
Roussel MF
Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
[TBL] [Abstract][Full Text] [Related]
14. C-terminal Src kinase (CSK) modulates insulin-like growth factor-I signaling through Src in 3T3-L1 differentiation.
Sekimoto H; Boney CM
Endocrinology; 2003 Jun; 144(6):2546-52. PubMed ID: 12746317
[TBL] [Abstract][Full Text] [Related]
15. A Src inhibitor regulates the cell cycle of human pluripotent stem cells and improves directed differentiation.
Chetty S; Engquist EN; Mehanna E; Lui KO; Tsankov AM; Melton DA
J Cell Biol; 2015 Sep; 210(7):1257-68. PubMed ID: 26416968
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of G1 phase cyclin dependent kinases by transforming growth factor beta 1.
Reddy KB; Hocevar BA; Howe PH
J Cell Biochem; 1994 Nov; 56(3):418-25. PubMed ID: 7876335
[TBL] [Abstract][Full Text] [Related]
17. The Shp-2 tyrosine phosphatase activates the Src tyrosine kinase by a non-enzymatic mechanism.
Walter AO; Peng ZY; Cartwright CA
Oncogene; 1999 Mar; 18(11):1911-20. PubMed ID: 10208413
[TBL] [Abstract][Full Text] [Related]
18. IKKalpha controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression.
Schneider G; Saur D; Siveke JT; Fritsch R; Greten FR; Schmid RM
EMBO J; 2006 Aug; 25(16):3801-12. PubMed ID: 16902410
[TBL] [Abstract][Full Text] [Related]
19. Src-dependent phosphorylation of ASAP1 regulates podosomes.
Bharti S; Inoue H; Bharti K; Hirsch DS; Nie Z; Yoon HY; Artym V; Yamada KM; Mueller SC; Barr VA; Randazzo PA
Mol Cell Biol; 2007 Dec; 27(23):8271-83. PubMed ID: 17893324
[TBL] [Abstract][Full Text] [Related]
20. RACK1: a novel substrate for the Src protein-tyrosine kinase.
Chang BY; Harte RA; Cartwright CA
Oncogene; 2002 Oct; 21(50):7619-29. PubMed ID: 12400005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
